Source: International Congress 2017 – Experimental PH
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Bordenave (Le Kremlin-Bicêtre Cedex, France). Neutralization of CXCL12 reverses established pulmonary hypertension in the sugen-hypoxia rat model. 2385

Member's Comments

No comment yet.

Related content which might interest you: Pirfenidone protects against pulmonary hypertension in the Sugen5416/hypoxia rat model Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018 Regulation of connexins by hypoxia in rat pulmonary vascular cells in an in vitro model of pulmonary hypertension Source: International Congress 2017 – Experimental PH Year: 2017 Specific ligand for the innate repair receptor, ARA290, attenuates pulmonary hypertension in an elastase-induced murine model of emphysema Source: International Congress 2017 – Experimental PH Year: 2017 Targeting aquaporin 1 reverses hypoxia-induced pulmonary hypertension in mice Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Reversal of pulmonary hypertension in a sugen/hypoxic rat model using an ASK1 inhibitor Source: International Congress 2017 – New perspectives from experimental models of pulmonary hypertension Year: 2017 Two rat models of hemolysis-induced pulmonary hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Characterisation of endogenous IL-33 using a model of Alternaria-induced pulmonary inflammation Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways Year: 2012 ACE2 activation improves pulmonary endothelial function and attenuates monocrotaline-induced pulmonary hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Macitentan modulates pulmonary mRNA levels of gremlin 1 in a rat model of pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Circulating fibrocyte recruitment and differentiation inhibited by treprostinil in pulmonary hypertension murine model Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Hypoxia-induced pulmonary artery fibroblast proliferation and migration is prevented by ASK1 inhibition in an in vitro cellular model of pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Role of NFATc3 in chronic hypoxia induced pulmonary hypertension in neonatal mice Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010 Inflammatory changes in a murine model of monocrotaline-induced pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 365s Year: 2005 Optimization of tissue targeting properties of macitentan, a new dual endothelin receptor antagonist, improves its efficacy in a rat model of pulmonary fibrosis associated with pulmonary arterial hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Reduction of endogenous acetylcholine contributes to pulmonary inflammation in a model of emphysema in mice Source: Annual Congress 2012 - The many roads to lung injury Year: 2012 Reversibility of the monocrotaline pulmonary hypertension rat model Source: Eur Respir J 2013; 42: 553-556 Year: 2013 Caspase inhibition reduces severe pulmonary hypertension in the AdTGF-1β/SU5416 model of angioproliferative pulmonary hypertension and lung fibrosis Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Vascular reverse remodeling in the mouse model of hypoxia-induced pulmonary hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Shroom expression is attenuated in hypoxia-induced pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 147s Year: 2006 R-Crizotinib predisposes to and exacerbates pulmonary arterial hypertension in animal models Source: Eur Respir J, 57 (5) 2003271; 10.1183/13993003.03271-2020 Year: 2021